MedTrace Logo

Comparative Effect of Palatal Injection in Pediatric Patient

NCT06025825 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2023-09-06

No results posted yet for this study

Summary

The aim of this study is to compare the pain perception of pediatric patients during extraction with and without palatal injection and to show whether articaine HCl and lidocaine HCl can provide palatal anesthesia in maxillary tooth extraction without the need for a second palatal injection. In addition, to evaluate the superiority of articaine HCl and lidocaine HCl to each other in providing local anesthesia and to compare pain control between each other. An observational prospective clinical study is planned to be performed in children aged 8-12 years with maxillary tooth extraction indication. It is planned to include 96 children in the study. Patients will be divided into 6 groups. After the application of anesthesia and after tooth extraction, the pain they feel with visual analogue scale and the level of pain observed with the Wong-Baker faces pain rating scale will be marked.

Conditions

  • Local Anesthetic Complication

Interventions

DRUG

Articaine Hydrochloride + Epinephrine

Buccal infiltration anesthesia + palatal infiltration anesthesia (with articaine HCl) was applied for first group Buccal infiltration anesthesia was applied and 5 minutes was waited before extraction. Buccal infiltration anesthesia was applied and 8 minutes was waited before extraction.

DRUG

Lidocaine Hydrochloride + Epinephrine

Buccal infiltration anesthesia + palatal infiltration anesthesia (with lidocaine HCl) was applied for second group Buccal infiltration anesthesia was applied and 5 minutes was waited before extraction for fourth group Buccal infiltration anesthesia was applied and 8 minutes was waited before extraction for sixth group

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    lead OTHER

Principal Investigators

  • ceren tatlı, assist.Prof · Ankara Yildirim Beyazıt University

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2023-08-28
Completion
2023-09-05
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06025825 on ClinicalTrials.gov